TEVA-FLURBIPROFEN 50 MG
FLURBIPROFEN : 50 MG · DIN 02100509 · TEVA CANADA LIMITED
Health Canada status: CANCELLED POST MARKET
What is TEVA-FLURBIPROFEN?
TEVA-FLURBIPROFEN 50 MG contains FLURBIPROFEN : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02100509, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 08-Aug-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02100509 |
|---|---|
| Brand name | TEVA-FLURBIPROFEN |
| Generic / active ingredient | FLURBIPROFEN : 50 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M01AE09 FLURBIPROFEN |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 08-Aug-2019 |
What can be used instead?
Other Canadian products sharing ATC code M01AE09 FLURBIPROFEN. 2 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLURBIPROFEN | 100 MG | TABLET | AA PHARMA INC | MARKETED | DIN 01912038 |
| FLURBIPROFEN | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 01912046 |
| ANSAID TABLETS 100 MG | 100 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00600792 |
| ANSAID TABLETS 50 MG | 50 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00647942 |
| FLURBIPROFEN-100 TAB 100MG | 100 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 01947737 |
| FLURBIPROFEN-50 TAB 50MG | 50 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 01947729 |
| FROBEN | 100 MG | TABLET | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 02223074 |
| FROBEN | 50 MG | TABLET | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 02223066 |
| FROBEN SR | 200 MG | CAPSULE (SUSTAINED-RELEASE) | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | DIN 02223082 |
| FROBEN TAB 100MG | 100 MG | TABLET | ORGANON CANADA LTD LTEE | CANCELLED POST MARKET | DIN 00593354 |
Who else supplies FLURBIPROFEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLURBIPROFEN appears in 15 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.